Animal models of central neuropathic pain

Neuromethods

Volumn 49, Issue , 2011, Pages 103-115

  Hains, Bryan ^a,b   Vera Portocarrero, Louis P ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; LIPOPOLYSACCHARIDE;

ALLERGIC ENCEPHALOMYELITIS; ALLODYNIA; BEHAVIOR CHANGE; CENTRAL NERVOUS SYSTEM INFECTION; CHRONIC PAIN; CONTUSION; DEMYELINATION; DISEASE MODEL; EXCITOTOXICITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERALGESIA; HYPERREFLEXIA; MIGRAINE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NERVE EXCITABILITY; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPINAL CORD COMPRESSION; SPINAL CORD HEMISECTION; SPINAL CORD INJURY; SPINAL CORD ISCHEMIA; SWISS JAMES LAMBERT MOUSE; WITHDRAWAL REFLEX;

ANIMALIA;

EID: 77957927869     PISSN: 08932336     EISSN: 19406045     Source Type: Book Series    
DOI: 10.1007/978-1-60761-880-5_7     Document Type: Review

References (70)

1. Aicher SA, Silverman MB, Winkler CW, Bebo Jr BF. Hyperalgesia in an animal model of multiple sclerosis. Pain 2004; 110:560-570.
2. Archibald CJ, McGrath PJ, Ritvo PG, Fisk JD, Bhan V, Maxner CE, et al. Pain prevalence, severity and impact in a clinical sample of mul-tiple sclerosis patients. Pain 1994; 58:89-93.
3. Basbaum AI, Clanton CH, Fields HL. Three bulbospinal pathways from the rostral medulla of the cat: an autoradiographic study of pain modulating systems. J Comp Neurol 1978; 178:209-224.
4. Basso DM, Beattie MS, Bresnahan JC. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 1996; 139(2):244-256.
5. Bebo Jr BF, Vandenbark AA, Offner H. Male SJL mice do not relapse after induction of EAE with PLP 139-152. J Neurosci Res 1996; 45:680-689.
6. Bourdette DN, Vandenbark AA, Meshul C, Whitham R, Offner H. Basic protein-specifc T-cell lines that induce experimental autoim-mune encephalomyelitis in SJL/J mice: com-parison with Lewis rat lines. Cell Immunol 1988; 112:351-363.
7. Bunge RP, Puckett WR, Becerra JL, Marcillo A, Quencer RM. Observations on the pathol-ogy of human spinal cord injury. A review and classifcation of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. Adv Neurol 1993; 59:75-89.
8. Christensen MD, Everhart AW, Pickelman JT, Hulsebosch CE. Mechanical and thermal allo-dynia in chronic central pain following spinal cord injury. Pain 1996; 68(1):97-107.
9. Christensen MD, Hulsebosch CE. Chronic central pain after spinal cord injury. J Neurotrauma 1997; 14(8):517-537.
10. Constantini S, Young W. The effects of meth-ylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats. J Neurosurg 1994; 80(1):97-111.
11. Cupini LM, Calabresi P. Medication-oversue headache: pathophysiological insights. J Headache Pain 2005; 6(4):199-202.
12. Cutrer FM. Pathophysiology of migraine. Semin Neurol 2006; 26(2):171-180.
13. Del Canto MC, Kim BS, Miller SD, Melvold RW. Theiler's murine encephalomyelitis virus (TMEV)-induced demyelination: a model for human multiple sclerosis. Methods 1996; 10:453-461.
14. Drescher KM, Pease LR, Rodriguez M. Antiviral immune responses modulate the nature of central nervous system (CNS) dis-ease in a murine model of multiple sclerosis. Immunol Rev 1997; 159:177-193.
15. Feniuk W, Humphrey PP, Perren MJ, Connor HE, Whalley ET. Rationale for the use of 5-HT1-like agonists in the treatment of migraine. J Neurol 1991; 238(Suppl 1):s57-s61.
16. Fields HL, Heinricher MM, Mason P. Neurotransmitters in nociceptive modulatory circuits. Annu Rev Neurosci 1991; 14: 219-245.
17. Fryze W, Zaborski J, Czlonkowska A. Pain in the course of multiple sclerosis. Neurol Neurochir Pol 2002; 36:275-284.
18. Ehde DM, Gibbons LE, Chwastiak L, Bonbardier CH, Sullivan MD, Kraft GH. Chronic pain in a large community sample of persons with multiple sclerosis. Mult Scler 2003; 9:605-611.
19. Gruner JA. A monitored contusion model of spinal cord injury in the rat. J Neurotrauma 1992; 9(2):123-126.
20. Hains BC, Klein JP, Saab CY, Craner MJ, Black JA, Waxman SG. Upregulation of sodium channel Nav1.3 and functional involvement in neuronal hyperexcitability associated with central neuropathic pain after spinal cord injury. J Neurosci 2003; 23(26): 8881-8892.
21. Hains BC, Saab CY, Waxman SG. Alterations in burst fring of thalamic VPL neurons and reversal by Na(v)1.3 antisense after spinal cord injury. J Neurophysiol 2006; 95(6): 3343-3352.
22. Hains BC, Saab CY, Waxman SG. Changes in electrophysiological properties and sodium channel Nav1.3 expression in thalamic neu-rons after spinal cord injury. Brain 2005; 128(Pt 10):2359-2371.
23. Hains BC, Waxman SG. Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J Neurosci 2006; 26(16):4308-4317.
24. Hao JX, Xu XJ, Aldskogius H, Seiger A, Wiesenfeld-Hallin Z. Allodynia-like effects in rat after ischaemic spinal cord injury photo-chemically induced by laser irradiation. Pain 1991; 45(2):175-185.
25. Holguin A, O'Connor KA, Biedenkapp J, Campisi J, Wieseler-Frank J, Milligan ED, Hansen MK, Spataro L, Maksimova E, Bravmann C, Martin D, Fleshner M, Maier SF, Watkins LR. HIV-1 gp120 stimulates proin-fammatory cytokine-mediated pain facilita-tion via activation of nitric oxide synthase-I (nNOS). Pain 2004; 110(3):517-530.
26. Hulsebosch CE, Xu GY, Perez-Polo JR, Westlund KN, Taylor CP, McAdoo DJ. Rodent model of chronic central pain after spinal cord contusion injury and effects of gabapentin. J Neurotrauma 2000; 17(12):1205-1217.
27. Jensen TS, Finnerup NB. Management of neuropathic pain. Curr Opin Support Palliat Care 2007; 1(2):126-131.
28. Joy J, Johnston RJ. Multiple sclerosis: current status and strategies for the future. Washington, DC: National Academy Press; 2000.
29. Koka P, He K, Zack JA, Kitchen S, Peacock W, Fried I, Tran T, Yashar SS, Merrill JE. Human immunodefciency virus-1 envelope proteins induce interleukin 1, tumor necrosis factor alpha, and nitric oxide in glial cultures derived from fetal, neonatal and adult human brain. J Exp Med 1995; 182:941-951.
30. Ledeboer A, Sloane EM, Milligan ED, Frank MG, Mahony JH, Maier SF, Watkins LR. Minocycline attenuates mechanical allodynia and proinfammatory cytokine expression in rat models of pain facilitation. Pain 2005; 115(1-2):71-83.
31. Ledeboer A, Gamanos M, Lai W, Martin D, Maier SF, Watkins LR, Quan N. Involvement of spinal cord nuclear factor kappaB activation in rat models if proinfammatory cytokine-mediated pain facilitation. Eur J Neurol 2005; 22(8):1977-1986.
32. Lin Q, Peng YB, Willis WD. Inhibition of primate spinothalamic tract neurons by spi-nal glycine and GABA is reduced during central sensitization. J Neurophysiol 1996; 76(2):1005-1014.
33. Lipton RB, Stewart WF, Scher AI. Epidemiology and economic impact of migraine. Curr Med Res Opin 2001; 17(Suppl 1):s4-s12.
34. Lynch JL, Gallus NJ, Ericson ME, Beitz AJ. Analysis of nociception, sex and peripheral nerve innervation in the TMEV animal model of multiple sclerosis. Pain 2008; 136:293-304.
35. Maratou K, Wallace VC Hasnie FS, Okuse K, Hosseini R, Jina N, Blackbeard J, Pheby T, Orengo C, Dickenson AH, McMahon SB, Rce AS. Comparison of dorsal root ganglion gene expression in rat models of traumatic HIV-associated neuropathic pain. Eur J Pain 2009; 13(4):387-398.
36. Martino G, Perkins MN. Tactile-induced ultrasonic vocalization in the rat: a novel assay to assess anti-migraine therapies in vivo. Cephalalgia 2008; 28(7):723-733.
37. McGavern DB, Murray PD, Rivera-Quinones C, Schmelzer JD, Low PA, Rodriguez M. Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neuro-logical defcits following demyelination in a chronic infammatory model of multiple scle-rosis. Brain 2000; 123:519-531.
38. McRae BL, Kennedy MK, Tan LJ, Dal Canto MC, Picha KS, Miller SD. Induction of active and adoptive relapsing experimental autoim-mune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid pro-tein. J Neuroimmunol 1992; 38:229-240.
39. Millan MJ. Descending control of pain. Prog Neurobiol 2002; 66(6):355-474.
40. Milligan ED, Mehmert KK, Hinde JL, Harvey LO, martin D, Tracey KJ, Maier SF, Watkins LR. Thermal hyperalgesia and mechanical allodynia produced by intrathecal administra-tion of the human immunodefciency virus-1 (HIV-1) envelope glycoprotein, gp120. Brain Res 2000; 861(1):105-116.
41. Milligan ED, O'Connor KA, Nguyen KT, Armstrong CB, Twining C, Gaykema RP, Holguin A, Martin D, Maier SF, Watkins LR. Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines. J Neurosci 2001; 21(8):2808-2819.
42. Milligan ED, O'Connor KA, Armstrong CB, Hansen MK, Martin D, Tracey KJ, Maier SF, Watkins LR. Systemic administration of CNI-1493, a p38 mitogen-activated protein kinase inhibitor, blocks intrathecal human immuno-defciency virus-1 gp120-induced enhanced pain states in rats. J Pain 2001; 2(6):326-333.
43. Mills CD, Hains BC, Johnson KM, Hulsebosch CE. Strain and model differences in behav-ioral outcomes after spinal cord injury in rat. J Neurotrauma 2001; 18(8):743-756.
44. Oleszak EL, Chang JR, Friedman H, Katsetos CD, Platsoucas CD. Thelier's virus infection: a model of multiple sclerosis. Clin Microbiol Rev 2004; 17(1):174-207.
45. Osterberg A, Boivie J, Thoumas K-A. Central pain in multiple sclerosis-prevalence and clini-cal characteristics. Eur J Pain 2005; 9:531-542.
46. Paterson PY. Experimental allergic encephalo-myelitis and autoimmune disease. Adv Immunol 1966; 5:131-208.
47. Paterson PY, Swanborg RH. Demyelinating diseases of th central and peripheral nervous system. In: Sampter M, Talmage DW, Frank MM, Austen KF, Claman HN, editors. Immunological disease. Boston: Little Brown and Col.; 1988. pp. 1877-1916.
48. Pender MP. Ascending impairment of nocice-ption in rats with experimental allergic enceph-alomyelitis. J Neurol Sci 1986; 75:317-328.
49. Perkins AT, Ondo W. When to worry about headache. Head pain as a clue to intracranial disease. Postgrad Med 1995; 98(2):197-201.
50. Perry VH, Andersson PB. The infammatory response in the CNS. Neuropathol Appl Neurobiol 1992; 18(5):454-459.
51. Rodriguez M, Leibowitz JL, Lampert PW. Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann Neurol 1993; 3:426-433.
52. Scheff SW, Rabchevsky AG, Fugaccia I, Main JA, Lumpp JE Jr. Experimental modeling of spinal cord injury: characterization of a force-defned injury device. J Neurotrauma 2003; 20(2):179-193.
53. Schoeniger-Skinner DK, Ledeboer A, Frank MG, Milligan ED, Poole S, Martin D, Maier SF, Watkins LR. Interleukin-6 mediates low-thresh-old mechanical allodynia induced by intrathecal HIV-1 envelope glycoprotein gp120. Brain Behav Immun 2007; 21(5):660-667.
54. Simone DA, Sorkin LS, Oh U, Chung JM, Owens C, LaMotte RH, Willis WD. Neurogenic hyperalgesia: central neural corre-lates in responses of spinothalamic tract neu-rons. J Neurophysiol 1991; 66(1):228-246.
55. Sundar SK, Cierpial MA, Kamaraju LS, Long S, Hsieh S, Lorenz C, Aaron M. Ritchie JC, Weiss JM. Human immunodefciency virus glycoprotein (gp120) infused into rat brain induces interleukin v1 to elevate pituitary-adrenal activity and decrease peripheral cellular immune responses. Proc Natl Acad Sci USA 1991; 88:11246-11250.
56. Svendsen KB, Jensen TS, Overvad K, Hansen HJ, Koch-Henriksen N, Bach FW. Pain in patients with multiple sclerosis: a population-based study. Arch Neurol 2003; 60:1089-1094. (Pubitemid 36975796)
57. Twining CM, Sloane EM, Schoeniger DK, Milligan ED, martin D, Marsch H, Maier SF, Watkins LR. Activation of the spinal cord complement cascade might contribute to mechanical allodynia induced by three animal models of spinal sensitization. J Pain 2005; 6(3):174-183.
58. Verma S, Estanislao L, Simpson D. HIV-associated neuropathic pain: epidemiology, pathophysiology and management. CNS Drugs 2005; 19(4):325-334.
59. Wallace VC, Blackbeard J, Segerdahl AR, Hasnie F, Pheby T, McMahon SB, Rice AS. Characterization of rodent models of HIV-gp120 and anti-retroviral- associated neuropathic pain. Brain 2007; 130:2688-2702.
60. Wallace VC, Blackbeard J, Pheby T, Segerdahl AR, Davies M, Hasnie F, Hall S, McMahon SB, Rics AS. Pharmacological, behavioral and mech-anistic analysis of HIV-1 gp120 induced painful neuropathy Pain 2007; 133(1-3):47-63.
61. Watkins LR, Milligan ED, Maier SF. Glial activation: a driving force of pathological pain. Trends Neurosci 2001; 24:450-455.
62. Watkins LR, Maier SF. Beyond neurons: evi-dence that immune and glial cells contribute to pathological pain states. Physiol Rev 2002; 82:981-1011.
63. White SR, Vyas D, Bieger D, Samathanam G. Monoamine-containing fber plexuses in the spinal cord of guinea pigs during paralysis, recovery and relapse stages of chronic relaps-ing experimental allergic encephalomyelitis. J Neuroimmunol 1989; 22:211-221.
64. Willer JC, De Broucker T, Le Bars D. Encoding of nociceptive thermal stimuli by diffuse noxious inhibitory controls in humans. J Neurophysiol 1989; 62(5):1028-1038.
65. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000; 288(5472):1765.
66. Xu XJ, Hao JX, Aldskogius H, Seiger A, Wiesenfeld-Hallin Z. Chronic pain-related syn-drome in rats after ischemic spinal cord lesion: a possible animal model for pain in patients with spinal cord injury. Pain 1992; 48(2):279-290.
67. Yezierski RP, Liu S, Ruenes GL, Kajander KJ, Brewer KL. Excitotoxic spinal cord injury: behavioral and morphological characteristics of a central pain model. Pain 1998; 75(1):141-155.
68. Yezierski RP, Park SH. The mechanosensitivity of spinal sensory neurons following intraspinal injections of quisqualic acid in the rat. Neurosci Lett 1993; 157(1):115-119.
69. Yezierski RP. Pain following spinal cord injury: pathophysiology and central mechanisms. Prog Brain Res 2000; 129:429-449.
70. Zhao P, Waxman SG, Hains BC. Extracellular signal-regulated kinase-regulated microglia-neuron signaling by prostaglandin E2 contributes to pain after spinal cord injury. J Neurosci 2007; 27(9):2357-2368.